SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-021992
Filing Date
2022-04-27
Accepted
2022-04-27 17:29:51
Documents
14
Period of Report
2022-04-25
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea158879-8k_enzobiochem.htm   iXBRL 8-K 28008
2 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ENZO BIOCHEM, INC ea158879ex3-1_enzobiochem.htm EX-3.1 60288
3 AMENDED AND RESTATED BY-LAWS OF ENZO BIOCHEM, INC ea158879ex3-2_enzobiochem.htm EX-3.2 90967
  Complete submission text file 0001213900-22-021992.txt   389342

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE enz-20220425.xsd EX-101.SCH 3018
5 XBRL LABEL FILE enz-20220425_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE enz-20220425_pre.xml EX-101.PRE 22586
8 EXTRACTED XBRL INSTANCE DOCUMENT ea158879-8k_enzobiochem_htm.xml XML 3580
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 22861131
SIC: 8071 Services-Medical Laboratories